The council is scheduled to meet Friday to call on the Ministry of Health, Labor and Welfare to take necessary steps for liberalization, including revising the pharmaceutical affairs law.
What does PAL stand for?
PAL stands for Pharmaceutical Affairs Law (medical manufacturing; various locations)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Military and Government
- Business, finance, etc.
See other definitions of PAL
We have 573 other meanings of PAL in our Acronym Attic
- Performing Arts Library (various locations)
- Permanent Artificial Lighting
- Permissible Alcohol Limit
- Permissive Action Link
- Personal Access Link (online banking)
- Personal Assistant for Leisure Activities (Canada; disabled person recreation access)
- Personal Audio Link (software)
- Personnel Airlock
- Personnel Allowance List
- Perspectives in American Literature (various schools)
- Phase Alternating Line
- Phase Alternation Line (television format)
- Philippine Airlines
- Phone Access Lookup (software to locate dial-up access telephone numbers)
- Phone and Locator (communication device)
- Photonic Air Link (fiber optics connectivity)
- Physics Abstraction Layer
- Picture Always Lousy
- Piece of Application Logic (computer kernel)
- Pilot Activated Lighting
Samples in periodicals archive:
With its new office in Tokyo, Japan, the company now is able to help US medical device manufacturers with issues such as the Japanese Pharmaceutical Affairs Law, quality management system implementation, reimbursement, medical distributor search and independent Designated Marketing Authorization Holder (D-MAH) representation.
Advising companies at the seminar on how to expand their excipient business in markets such as China and Russia, Carl Mroz, Director of Regulatory Affairs at Colorcon and Chair of IPEC Europe's Regulatory Affairs Committee, pointed out that Japan recently amended its 1948 Pharmaceutical Affairs Law to allow for the filing of an EMF (Excipient Master File) and that European stakeholders should focus on achieving this in Europe as well.
In Japan, a revised version of the Pharmaceutical Affairs Law that took effect this year is increasing manufacturers' flexibility for product marketing.
Japan in July 2003 revised its Pharmaceutical Affairs Law, which curtailed the use of malachite green in egg incubation facilities and fish farms.
The lower house also approved a revision bill for the Pharmaceutical Affairs Law, which aims mainly to tighten state control of medicines produced from animal cells, including blood products, in a bid to prevent infection from unknown viruses.